Galectin Therapeutics: Q3 Earnings Insights

Galectin Therapeutics (NASDAQ:GALT) reported its Q3 earnings results on Monday, November 13, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Galectin Therapeutics missed estimated earnings by 50.0%, reporting an EPS of $-0.24 versus an estimate of $-0.16.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 7.38% increase in the share price the next day.

To track all earnings releases for Galectin Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.